Influenza-associated mortality in Hong Kong

Clinical Infectious Diseases

Volumn 39, Issue 11, 2004, Pages 1611-1617

  Wong, Chit Ming ^a   Chan, King Pan ^a   Hedley, Anthony Johnson ^a   Peiris, J S Malik ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AGED; ARTICLE; CLIMATE; CONTROLLED STUDY; FEMALE; HONG KONG; HUMAN; INFLUENZA; INFLUENZA VACCINATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POISSON DISTRIBUTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; TROPICS;

ADULT; AGED; CAUSE OF DEATH; HONG KONG; HUMANS; INFLUENZA, HUMAN; MIDDLE AGED;

EID: 9644276994     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/425315     Document Type: Article

References (37)

1. World Health Organization. Adoption of global agenda on influenza. Wkly Epidemiol Rec 2002; 77:191-5.
2. Nicholson KG. Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990. Epidemiol Infect 1996; 116:51-63.
3. Bisno AL, Griffin JP, Van Epps KA, Niell HB, Rytel MW. Pneumonia and Hong Kong influenza: a prospective study of the 1968-69 epidemic. Am J Med Sci 1971; 261:251-63.
4. Douglas RG. Influenza: the disease and its complications. Hosp Pract 1976; 11:43-50.
5. Davis JW, Lee E, Taira DA, Chung RS. Influenza vaccination, hospitalizations, and costs among members of a Medicare managed care plan. Med Care 2001; 39:1273-80.
6. Serfling RE. Methods for current statistical analysis of excess pneumonia-influenza deaths. Public Health Rep 1963; 78:494-506.
7. Choi K, Thacker SB. An evaluation of influenza mortality surveillance, 1962-1979. I. Time series forecasts of expected pneumonia and influenza deaths. Am J Epidemiol 1981; 113:215-26.
8. Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996; 18:64-76.
9. Han LL, Alexander JP, Anderson LJ. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis 1999; 179:25-30.
10. Zambon MC, Stockton JD, Clewley JP, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 2001; 358:1410-6.
11. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997; 87:1944-50.
12. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2002; 51:(RR-3):1-31.
13. Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine 1999; 17:S3-10.
14. Jennings LC, Regnery HL. Influenza epidemiology in the Pacific Basin. In: Brown LE, Hampson AW, Webster RG, eds. Options for the control of influenza III. International Congress Series 1123. Amsterdam: Elsevier, 1996:85-9.
15. Shortridge KF, Stuart-Harris CH. An influenza epicentre? Lancet 1982; 2:812-3.
16. Yuen KY, Chan PKS, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351:467-71.
17. Fitzner KA, Shortridge KF, McGhee SM, Hedley AJ. Cost effectiveness study on influenza prevention in Hong Kong. Health Policy 2001; 56: 215-34.
18. Fitzner KA, McGhee SM, Hedley AJ, Shortridge KF. Influenza surveillance in Hong Kong: results of a trial Physician Sentinel Program. Hong Kong Med J 1999; 5:87-94.
19. Monto AS, Gravenstein S, Elliott M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med 2000; 160: 3243-7.
20. Census and Statistics Department. Hong Kong Special Administrative Region. 1996-1999 Known death microdata sets. 10 January 2003. Available at: http://www.info.gov.hk/censtatd/home.html. Accessed 1 April 2004.
21. Hong Kong Observatory, Hong Kong Special Administrative Region. Extract of meteorological observations for Hong Kong. 4 May 2003. Available at: http://www.hko.gov.hk/wxinfo/pastwx/extract.htm. Accessed 1 April 2004.
22. Chiu SS, Lau YL, Chan KH, Wong WH, Peiris JS. Influenza-related hospitalization among children in Hong Kong. N Engl J Med 2002; 347:2097-103.
23. Thompson W, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-86.
24. Sprenger M, Van Naelten MA, Masurel N. Influenza mortality and excess deaths in the elderly, 1967-82. Epidemiol Infect 1989; 103:633-41.
25. Greenland S, Drescher K. Maximum likelihood estimate of the attributable fraction from logistic model. Biometrics 1993; 49:865-72.
26. S-plus [computer program]. Version 3.4. Seattle: StatSci, 1996.
27. Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Griffin MR. The effect of influenza on hospitalizations, outpatients visits and courses of antibiotics in children. N Engl J Med 2000; 342:225-31
28. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000; 342:232-9.
29. Thompson W, Brammer L, Shay E, et al. Alternative models for estimating influenza attributable P&I deaths in the US. In: Osterhaus ADME, Cox N, Hampson A, eds. Options for the control of influenza. International Congress Series 1219. Amsterdam: Elsevier, 2001:33-6.
30. Ng TP, Pwee KH, Niti M, Weintraub E, Cox N, Fukuda K. Influenza in Singapore: assessing the burden of illness in the community. Ann Acad Med Singapore 2002; 31:182-8.
31. Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000; 102:3039-45.
32. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003; 348:1322-32.
33. Jackson LA, Yu O, Heckbert SR, et al. Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol 2002; 156:634-40.
34. Gurfinkel EP, de la Fuente RL, Mendiz O, et al. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous cornary interventions. Circulation 2002; 105:2143-7.
35. Gurfinkel EP, de la Fuente RL, Mendiz O, Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study. Eur Heart J 2004; 25:25-31.
36. Epstein SE, Zhou YF, Shu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999; 100:e20-8.
37. Naghavi M, Wyde P, Litovsky S, et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atheroslerotic plaques of apolipoprotein E-deficient mice. Circulation 2003; 107:762-8.